Pluri Inc.
PLUR.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.9M
Close$
Share Statistics
| Market cap | $10.90 Million |
|---|---|
| Enterprise Value | $14.92 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 108.77% |
|---|---|
| Return on Assets | -155.16% |
| Return on Invested Capital | 152.28% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 14.68 |
| Enterprise Value to EBIT | -0.59 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | -0.33 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pluri Inc
152 employees
CEO: Zalman Aberman Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell...